Pheochromocytoma: An overlooked reversible cause of heart failure with reduced ejection fraction
Yıl: 2021 Cilt: 49 Sayı: 6 Sayfa Aralığı: 501 - 508 Metin Dili: İngilizce DOI: 10.5543/tkda.2021.86087 İndeks Tarihi: 29-01-2022
Pheochromocytoma: An overlooked reversible cause of heart failure with reduced ejection fraction
Öz: Summary– Pheochromocytoma is a rare, benign tumor of adrenal medulla, and its clinical symptoms are related to catecholamine production. Clinical presentation may vary in a broad spectrum. Dilated or hypertrophied cardiomyopathies are the possible clinical outcomes of pheochromocytoma. Pheochromocytoma should be kept in mind in the differential diagnosis where resistant hypertension, palpitations, headache, and sweating accompany cardiomyopathy. Excessive adrenergic stimulation causing catecholamine discharge can trigger hypertension crisis, pulmonary edema, and myocardial necrosis. Here in this report, we aimed to present the case of a patient with pheochromocytoma related cardiomyopathy who was totally recovered after surgical excision of the tumor
Anahtar Kelime: Feokromasitoma: Düşük ejeksiyon fraksiyonlu kalp yetmezliğinin gözden kaçan geri döndürülebilir bir nedeni
Öz: Özet– Feokromasitoma benign karakterde olup katekolamin salınımı ile klinik semptomlar oluşturan adrenal medulla ile ilişkili nadir görülen bir tümördür. Hastaların klinik prezentasyonları oldukça değişken bir spektrum gösterebilir. Dilate veya hipertrofik kardiyomiyopati feokromasitomanın olası klinik sonuçlarından biridir. Kalıcı hipertansiyon, çarpıntı, baş ağrısı ve terleme kardiyomiyopatiye eşlik ediyorsa, ayırıcı tanıda feokromasitoma akılda bulundurulmalıdır. Katekolamin deşarjına neden olan aşırı adrenerjik uyarı, hipertansif krizi, pulmoner ödemi ve miyokardiyal hasarı tetikleyebilir. Bu yazıda cerrahi tedavi sonrasında kardiyomiyopatinin tamamen gerilediği feokromasitoma hastasının sunumunu yapmayı amaçladık.
Anahtar Kelime: Belge Türü: Makale Makale Türü: Olgu Sunumu Erişim Türü: Erişime Açık
- 1. Gu YW, Poste J, Kunal M, Schwarcz M, Weiss I. Cardiovascular manifestations of pheochromocytoma. Cardiology Rev 2017;25:215-222. [Crossref]
- 2. Chen X, Liu X, Tian S, Wang X, Tang H, Yu Y, et al. Cardiac arrest and catecholamine cardiomyopathy secondary to a misdiagnosed ectopic pheochromocytoma. Endokrynol Pol 2020;71:479-80. [Crossref]
- 3. Galetta F, Franzoni F, Bernini G, Poupak F, Carpi A, Cini G, et al. Cardiovascular complications in patients with pheochromocytoma: a mini-review. Biomed Pharmacother 2010;64:505-9. [Crossref]
- 4. Perry CG, Sawka AM, Singh R, Thabane L, Bajnarek J, Young Jr WF. The diagnostic efficacy of urinary fractionated metanephrines measured by tandem mass spectrometry in detection of pheochromocytoma. Clin Endocrinol (Oxf) 2007;66:703-8. [Crossref]
- 5. Lenders JW, Duh QY, Eisenhofer G, Gimenez-Roqueplo AP, Grebe SK, Murad MH, et al. Pheochromocytoma and paraganglioma: an endocrine society clinical practice guideline. J Clin Endocrinol Metab 2014;99:1915-42. [Crossref]
- 6. Batisse-Lignier M, Pereira B, Motreff P, Pierrard R, Burnot C, Vorilhon C, et al. Acute and chronic pheochromocytoma-induced cardiomyopathies: different prognoses? A systematic analytical review. Medicine (Baltimore) 2015;94:e2198. [Crossref]
- 7. Gagnon N, Mansour S, Bitton Y, Bourdeau I. Takotsubo-like cardiomyopathy in a large cohort of patients with pheochromocytoma and paraganglioma. Endocr Pract 2017;23:1178- 92. [Crossref]
- 8. Rostoff P, Krawczyk K, Krupinski M, Majda A, Golinska-Grzybala K, Kiecana J, et al. Catecholamine-induced secondary Takotsubo syndrome in a patient with pheochromocytoma and synchronous papillary renal cell carcinoma. Kardiologia Polska 2020;78:784-5. [Crossref]
- 9. Rostoff P, Nessler B, Pikul P, Golinska-Grzybala K, Miszalski-Jamka T, Nessler J. Fulminant adrenergic myocarditis complicated by pulmonary edema, cardiogenic shock and cardiac arrest. Am J Emerg Med 2018;36:344.e1-344.e4. [Crossref]
- 10. Prejbisz A, Lenders JWM, Eisenhofer G, Januszewicz A. Cardiovascular manifestations of phaeochromocytoma. J Hypertens 2011;29:2049-60. [Crossref]
| APA | Çoner A, Özyıldız A (2021). Pheochromocytoma: An overlooked reversible cause of heart failure with reduced ejection fraction. , 501 - 508. 10.5543/tkda.2021.86087 |
| Chicago | Çoner Ali,Özyıldız Ali Gökhan Pheochromocytoma: An overlooked reversible cause of heart failure with reduced ejection fraction. (2021): 501 - 508. 10.5543/tkda.2021.86087 |
| MLA | Çoner Ali,Özyıldız Ali Gökhan Pheochromocytoma: An overlooked reversible cause of heart failure with reduced ejection fraction. , 2021, ss.501 - 508. 10.5543/tkda.2021.86087 |
| AMA | Çoner A,Özyıldız A Pheochromocytoma: An overlooked reversible cause of heart failure with reduced ejection fraction. . 2021; 501 - 508. 10.5543/tkda.2021.86087 |
| Vancouver | Çoner A,Özyıldız A Pheochromocytoma: An overlooked reversible cause of heart failure with reduced ejection fraction. . 2021; 501 - 508. 10.5543/tkda.2021.86087 |
| IEEE | Çoner A,Özyıldız A "Pheochromocytoma: An overlooked reversible cause of heart failure with reduced ejection fraction." , ss.501 - 508, 2021. 10.5543/tkda.2021.86087 |
| ISNAD | Çoner, Ali - Özyıldız, Ali Gökhan. "Pheochromocytoma: An overlooked reversible cause of heart failure with reduced ejection fraction". (2021), 501-508. https://doi.org/10.5543/tkda.2021.86087 |
| APA | Çoner A, Özyıldız A (2021). Pheochromocytoma: An overlooked reversible cause of heart failure with reduced ejection fraction. Türk Kardiyoloji Derneği Arşivi, 49(6), 501 - 508. 10.5543/tkda.2021.86087 |
| Chicago | Çoner Ali,Özyıldız Ali Gökhan Pheochromocytoma: An overlooked reversible cause of heart failure with reduced ejection fraction. Türk Kardiyoloji Derneği Arşivi 49, no.6 (2021): 501 - 508. 10.5543/tkda.2021.86087 |
| MLA | Çoner Ali,Özyıldız Ali Gökhan Pheochromocytoma: An overlooked reversible cause of heart failure with reduced ejection fraction. Türk Kardiyoloji Derneği Arşivi, vol.49, no.6, 2021, ss.501 - 508. 10.5543/tkda.2021.86087 |
| AMA | Çoner A,Özyıldız A Pheochromocytoma: An overlooked reversible cause of heart failure with reduced ejection fraction. Türk Kardiyoloji Derneği Arşivi. 2021; 49(6): 501 - 508. 10.5543/tkda.2021.86087 |
| Vancouver | Çoner A,Özyıldız A Pheochromocytoma: An overlooked reversible cause of heart failure with reduced ejection fraction. Türk Kardiyoloji Derneği Arşivi. 2021; 49(6): 501 - 508. 10.5543/tkda.2021.86087 |
| IEEE | Çoner A,Özyıldız A "Pheochromocytoma: An overlooked reversible cause of heart failure with reduced ejection fraction." Türk Kardiyoloji Derneği Arşivi, 49, ss.501 - 508, 2021. 10.5543/tkda.2021.86087 |
| ISNAD | Çoner, Ali - Özyıldız, Ali Gökhan. "Pheochromocytoma: An overlooked reversible cause of heart failure with reduced ejection fraction". Türk Kardiyoloji Derneği Arşivi 49/6 (2021), 501-508. https://doi.org/10.5543/tkda.2021.86087 |
